Literature DB >> 10392672

The use of continuous positive airway pressure by face mask and thoracic epidural analgesia after lung transplantation. Gothenburg Lung Transplant Group.

A Westerlind1, F Nilsson, S E Ricksten.   

Abstract

OBJECTIVE: To evaluate the clinical use of continuous positive airway pressure (CPAP) and thoracic epidural analgesia (TEA) after lung transplantation (LTx).
DESIGN: Retrospective case series.
SETTING: Cardiothoracic intensive care unit (ICU) at a university hospital. PARTICIPANTS: All heart-lung, bilateral, and single-lung transplant recipients between 1990 and 1996 at this institution (n = 102).
INTERVENTIONS: Postoperative pain was controlled by a thoracic epidural infusion of bupivacaine, 1 mg/mL, and sufentanil, 1 microg/mL. After extubation, CPAP, 5 to 10 cm H2O by face mask, was used to prevent reperfusion edema.
MEASUREMENTS AND MAIN RESULTS: In 99 patients, the length of ventilation (LOV) was a median of 4.3 hours (range, 1.0 to 312.0 hours). The median LOV was 8.0 hours (range, 1.5 to 41.0 hours) in the heart-lung recipients, 4.5 hours (range, 2.0 to 47.0 hours) in the bilateral-lung recipients, and 3.5 hours (range, 1.0 to 312.0 hours) in the single-lung recipients. Three transplant recipients, all with primary pulmonary hypertension, were prematurely extubated and reintubated because of pulmonary edema. Twelve hours after extubation, the median oxygenation index (PaO2/F(I)O2, PaO2 in kilopascal units) was greater than 35. The median ICU length of stay for all transplant recipients was 4 days (range, 2 to 270 days).
CONCLUSION: The postoperative use of CPAP and TEA is associated with early and safe tracheal extubation after LTx and may shorten ICU stay.

Entities:  

Mesh:

Year:  1999        PMID: 10392672     DOI: 10.1016/s1053-0770(99)90258-6

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  2 in total

1.  Effect of high-flow nasal therapy on patient-centred outcomes in patients at high risk of postoperative pulmonary complications after cardiac surgery: a study protocol for a multicentre adaptive randomised controlled trial.

Authors:  Melissa Earwaker; Sofia Villar; Julia Fox-Rushby; Melissa Duckworth; Sarah Dawson; Jo Steele; Yi-da Chiu; Edward Litton; Gudrun Kunst; Gavin Murphy; Guillermo Martinez; Vasileios Zochios; Val Brown; Geoff Brown; Andrew Klein
Journal:  Trials       Date:  2022-03-28       Impact factor: 2.728

2.  The effect of high-flow nasal oxygen on hospital length of stay in cardiac surgical patients at high risk for respiratory complications: a randomised controlled trial.

Authors:  V Zochios; T Collier; G Blaudszun; A Butchart; M Earwaker; N Jones; A A Klein
Journal:  Anaesthesia       Date:  2018-07-18       Impact factor: 6.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.